| Peptide-guided nanoparticles for glioblastoma targeting P Säälik, P Lingasamy, K Toome, I Mastandrea, L Rousso-Noori, A Tobi, ... Journal of controlled release 308, 109-118, 2019 | 64 | 2019 |
| Plectin interacts with the rod domain of type III intermediate filament proteins desmin and vimentin B Favre, Y Schneider, P Lingasamy, JE Bouameur, N Begré, Y Gontier, ... European journal of cell biology 90 (5), 390-400, 2011 | 62 | 2011 |
| Tumor-penetrating peptide for systemic targeting of Tenascin-C P Lingasamy, A Tobi, K Kurm, S Kopanchuk, A Sudakov, M Salumäe, ... Scientific Reports 10 (1), 5809, 2020 | 43 | 2020 |
| Bi-specific tenascin-C and fibronectin targeted peptide for solid tumor delivery P Lingasamy, A Tobi, M Haugas, H Hunt, P Paiste, T Asser, T Rätsep, ... Biomaterials 219, 119373, 2019 | 42 | 2019 |
| Interaction of plectin with keratins 5 and 14: dependence on several plectin domains and keratin quaternary structure JE Bouameur, B Favre, L Fontao, P Lingasamy, N Begré, L Borradori Journal of Investigative Dermatology 134 (11), 2776-2783, 2014 | 42 | 2014 |
| Phosphorylation of serine 4642 in the COOH-extremity of plectin by MNK2 and PKA modulates its interaction with intermediate filaments BFLB Jamal-Eddine Bouameur, Yann Schneider, Nadja Begré, Ryan P. Hobbs ... Journal of Cell Science 126, 2013 | 37 | 2013 |
| Homing peptides for cancer therapy P Lingasamy, T Teesalu Bio-Nanomedicine for Cancer Therapy, Advances in Experimental Medicine and …, 2021 | 24 | 2021 |
| Hyaluronan-binding peptide for targeting peritoneal carcinomatosis H Ikemoto, P Lingasamy, AM Anton Willmore, H Hunt, K Kurm, O Tammik, ... Tumor Biology 39 (5), 1010428317701628, 2017 | 24 | 2017 |
| Exposed CendR domain in homing peptide yields skin-targeted therapeutic in epidermolysis bullosa T Pemmari, L Ivanova, U May, P Lingasamy, A Tobi, A Pasternack, ... Molecular therapy 28 (8), 1833-1845, 2020 | 22 | 2020 |
| Tumor penetrating peptide-functionalized Tenascin-C antibody for glioblastoma targeting P Lingasamy, AH Laarmann, T Teesalu Current cancer drug targets 21 (1), 70-79, 2021 | 12 | 2021 |
| Homing peptide-based targeting of tenascin-C and fibronectin in endometriosis L Simón-Gracia, K Kiisholts, V Petrikaitė, A Tobi, M Saare, P Lingasamy, ... Nanomaterials 11 (12), 3257, 2021 | 10 | 2021 |
| Desmoplakin interacts with the coil 1 of different types of intermediate filament proteins and displays high affinity for assembled intermediate filaments B Favre, N Begré, JE Bouameur, P Lingasamy, GM Conover, L Fontao, ... PloS one 13 (10), e0205038, 2018 | 9 | 2018 |
| PL1 peptide engages acidic surfaces on tumor-associated fibronectin and tenascin isoforms to trigger cellular uptake P Lingasamy, K Põšnograjeva, S Kopanchuk, A Tobi, A Rinken, ... Pharmaceutics 13 (12), 1998, 2021 | 8 | 2021 |
| Bio-Nanomedicine for Cancer Therapy P Lingasamy, T Teesalu Springer, 2021 | 5 | 2021 |
| Development of multitargeted tumor penetrating peptides P Lingasamy Ph. D. Thesis, University of Tartu, Available online: http://hdl.handle.net …, 2020 | 5 | 2020 |
| BI-SPECIFIC EXTRACELLULAR MATRIX BINDING PEPTIDES AND METHODS OF USE THEREOF T Teesalu, P Lingasamy WO Patent WO2,020,161,602, 2022 | 3 | 2022 |
| Intravitreal CendR peptides target laser-induced choroidal neovascularization sites in mice J Puranen, S Korhonen, M Haugas, P Lingasamy, T Teesalu, A Subrizi, ... Journal of Controlled Release 360, 810-817, 2023 | 2 | 2023 |
| Exploring immunome and microbiome interplay in reproductive health: current knowledge, challenges, and novel diagnostic tools P Lingasamy, V Modhukur, R Mändar, A Salumets Seminars in Reproductive Medicine, 2024 | 1 | 2024 |
| MBMethPred: A Computational Framework for the Accurate Classification of Childhood Medulloblastoma Subgroups Using Data Integration and AI-Based Approaches ES Rahmani, A Lawarde, P Lingasamy, S Vela Moreno, A Salumets, ... Frontiers in Genetics 14, 1233657, 2023 | | 2023 |
| Tenascin-C binding peptides for cancer targeting P Lingasamy, A Tobi, H Hunt, P Säälik, M Salumäe, T Teesalu, T Teesalu Cancer Research 76 (14_Supplement), 2164-2164, 2016 | | 2016 |
Tambet TeesaluUniversity of Tartu, EstoniaVerified email at ut.ee
